Jazz Pharma (JAZZ) Begins Zepzelca Confirmatory Study for SCLC

Jazz Pharmaceuticals (JAZZ) and partner PharmaMar initiate a late-stage study to evaluate Zepzelca in metastatic SCLC. Data from the study will support full approval of the drug for the indication.